Fanconi Anemia Pathway Deficiency Drives Copy Number Variation in Squamous Cell Carcinomas
暂无分享,去创建一个
Thomas E Heineman | P. Campbell | M. Imieliński | A. Koren | J. Wagner | Bhuvanesh Singh | J. Surrallés | D. Kutler | O. Fedrigo | A. Auerbach | M. Sanders | M. MacMillan | S. Chandrasekharappa | F. Donovan | A. Smogorzewska | Sunandini Sridhar | S. Wells | Kevin Hadi | Huasong Tian | J. Rosiene | Lorenzo Bean | E. Velleuer | R. Dietrich | Ji-Dung Luo | F. Boulad | T. Scognamiglio | K. Patel | Francis P Lach | Francis P. Lach | G. Bagby | R. Tryon | O. Rosti | Jennifer A. Kennedy | J. Rastatter | Ryan R. White | M. Cancio | Audrey Goldfarb | Matthew M. Edwards | R. Vaughan | M. Jung | A. L. Webster | Raymond J Noonan | A. Rosenberg | T. Carrol | Ashlyn Gonzalez | L. Bean | Frank X. Donovan | Rebecca K Tryon | J. Wagner
[1] A. Smogorzewska,et al. Endogenous formaldehyde destroys blood stem cells. , 2021, Blood.
[2] Liwu Fu,et al. The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment , 2021, Acta pharmaceutica Sinica. B.
[3] Inigo Martincorena,et al. Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing , 2020, Nature Protocols.
[4] M. Nagasaki,et al. Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome , 2020, Science advances.
[5] C. R. Leemans,et al. Head and neck squamous cell carcinoma , 2020, Nature Reviews Disease Primers.
[6] S. Chandrasekharappa,et al. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant , 2020, Cold Spring Harbor molecular case studies.
[7] Nicola K. Wilson,et al. Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans , 2020, Molecular cell.
[8] P. Ceppi,et al. Targeting EMT in Cancer with Repurposed Metabolic Inhibitors. , 2020, Trends in cancer.
[9] J. Grandis,et al. Alterations and molecular targeting of the GSK-3 regulator, PI3K, in head and neck cancer. , 2020, Biochimica et biophysica acta. Molecular cell research.
[10] Alfred Böcking,et al. Diagnostic accuracy of brush biopsy–based cytology for the early detection of oral cancer and precursors in Fanconi anemia , 2020, Cancer cytopathology.
[11] Nuno A. Fonseca,et al. Patterns of somatic structural variation in human cancer genomes , 2020, Nature.
[12] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[13] Icgc,et al. Pan-cancer analysis of whole genomes , 2017, bioRxiv.
[14] Mihai I Truica,et al. Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy. , 2019, Cancer cell.
[15] H. Rugo,et al. Alpelisib for PIK3CA‐Mutated, Hormone Receptor–Positive Advanced Breast Cancer , 2019, The New England journal of medicine.
[16] N. Lee,et al. Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature , 2019, Head & neck.
[17] Simion I. Chiosea,et al. Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer , 2019, The Journal of experimental medicine.
[18] T. Crawford,et al. Chromosome instability syndromes , 2018, Nature Reviews Disease Primers.
[19] M. Stratton,et al. The mutational landscape of normal human endometrial epithelium , 2018, bioRxiv.
[20] Yassen Assenov,et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.
[21] Véronique Geoffroy,et al. AnnotSV: an integrated tool for structural variations annotation , 2018, Bioinform..
[22] G. Turcatti,et al. Targeting STING with covalent small-molecule inhibitors , 2018, Nature.
[23] David T. Long,et al. The evolving role of DNA inter-strand crosslinks in chemotherapy. , 2018, Current opinion in pharmacology (Print).
[24] Joshua M. Stuart,et al. Resource Genomic , Pathway Networ k , and Immunologic Features Distinguishing Squamous Carcinomas Graphical , 2018 .
[25] M. Stratton,et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells , 2018, Nature.
[26] Samuel F. Bakhoum,et al. Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.
[27] Edison T. Liu,et al. Mechanism of tandem duplication formation in BRCA1 mutant cells , 2017, Nature.
[28] P. Rosenberg,et al. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up , 2017, Haematologica.
[29] Michael C. Schatz,et al. Accurate detection of complex structural variations using single molecule sequencing , 2017, Nature Methods.
[30] Martin A. M. Reijns,et al. cGAS surveillance of micronuclei links genome instability to innate immunity , 2017, Nature.
[31] Dennis E Discher,et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei , 2017, Nature.
[32] Rob Patro,et al. Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.
[33] Benjamin J. Raphael,et al. Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.
[34] Qiang Sun,et al. The Papillomavirus Episteme: a major update to the papillomavirus sequence database , 2016, Nucleic Acids Res..
[35] Paul Flicek,et al. The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data , 2016, Nucleic Acids Res..
[36] Andrew Menzies,et al. ascatNgs: Identifying Somatically Acquired Copy‐Number Alterations from Whole‐Genome Sequencing Data , 2016, Current protocols in bioinformatics.
[37] Allison P. Heath,et al. Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.
[38] A. D’Andrea,et al. The Fanconi anaemia pathway: new players and new functions , 2016, Nature Reviews Molecular Cell Biology.
[39] David C. Jones,et al. Landscape of somatic mutations in 560 breast cancer whole genome sequences , 2016, Nature.
[40] Jeffrey H. Chuang,et al. The tandem duplicator phenotype as a distinct genomic configuration in cancer , 2016, Proceedings of the National Academy of Sciences.
[41] Eric Talevich,et al. CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing , 2016, PLoS Comput. Biol..
[42] J. Radford. Nivolumab for recurrent squamous-cell carcinoma of the head and neck , 2016, BDJ.
[43] M. Robinson,et al. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. , 2015, F1000Research.
[44] K. J. Patel,et al. Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen , 2015, Molecular cell.
[45] J. Grandis,et al. Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer , 2015, PloS one.
[46] Elizabeth E. Hoskins,et al. Oral Human Papillomavirus Is Common in Individuals with Fanconi Anemia , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[47] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[48] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[49] A. Smogorzewska,et al. SnapShot: Fanconi Anemia and Associated Proteins , 2015, Cell.
[50] Benjamin J. Raphael,et al. Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data , 2014, Bioinform..
[51] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[52] Lars Feuk,et al. The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..
[53] K. Cimprich,et al. Causes and consequences of replication stress , 2013, Nature Cell Biology.
[54] S. Miyano,et al. Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. , 2013, Blood.
[55] M. Schiffman,et al. Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: A search for human papillomavirus , 2013, International journal of cancer.
[56] M. Rowicka,et al. Nucleotide-resolution DNA double-strand breaks mapping by next-generation sequencing , 2013, Nature Methods.
[57] Heng Li. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.
[58] L. Staudt,et al. Identification of Early Replicating Fragile Sites that Contribute to Genome Instability , 2013, Cell.
[59] Molly C. Kottemann,et al. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks , 2013, Nature.
[60] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..
[61] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[62] Paz Polak,et al. Differential relationship of DNA replication timing to different forms of human mutation and variation. , 2012, American journal of human genetics.
[63] Gabor T. Marth,et al. Haplotype-based variant detection from short-read sequencing , 2012, 1207.3907.
[64] Francesca Chiaromonte,et al. A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome? , 2012, Genome research.
[65] Elizabeth E. Hoskins,et al. The Fanconi Anemia Pathway Limits Human Papillomavirus Replication , 2012, Journal of Virology.
[66] D. Kutler,et al. Postoperative clinical radiosensitivity in patients with fanconi anemia and head and neck squamous cell carcinoma. , 2011, Archives of otolaryngology--head & neck surgery.
[67] C. Cole,et al. COSMIC: the catalogue of somatic mutations in cancer , 2011, Genome Biology.
[68] K. J. Patel,et al. Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice , 2011, Nature.
[69] E. Fuchs,et al. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling , 2011, Proceedings of the National Academy of Sciences.
[70] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[71] P. Deloukas,et al. Signatures of mutation and selection in the cancer genome , 2010, Nature.
[72] E. Fuchs,et al. Isolation and culture of epithelial stem cells. , 2009, Methods in molecular biology.
[73] C. R. Leemans,et al. Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. , 2008, Journal of the National Cancer Institute.
[74] Bhuvanesh Singh,et al. Downregulation of Fanconi Anemia Genes in Sporadic Head and Neck Squamous Cell Carcinoma , 2007, ORL.
[75] Christopher U. Jones,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.
[76] A. D’Andrea,et al. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. , 2005, Human molecular genetics.
[77] Mei Liu,et al. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival , 2004, Oncogene.
[78] A. Auerbach,et al. First announcement of the Fanconi anemia International Registry , 1982, Human Genetics.
[79] J. Satagopan,et al. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. , 2004, Journal of the National Cancer Institute.
[80] Marianne Berwick,et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). , 2003, Blood.
[81] J. Shah,et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. , 2003, Archives of otolaryngology--head & neck surgery.
[82] R. Benz,et al. Sensitivity to five mutagens in Fanconi's anemia as measured by the micronucleus method. , 1978, Cancer research.
[83] A. Auerbach,et al. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens , 1976, Nature.
[84] M. Sasaki,et al. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. , 1973, Cancer research.